Cas 477202-00-9 Monoclonal Antibody Ipilimumab Breast Cancer
Price:
Negotiable
MOQ:
1g
Delivery Time:
Negotiable
Brand:
Crene
Product Description
Cas 477202-00-9 Monoclonal Antibody Ipilimumab Breast Cancer
Chemical Information
| Product name:Ipilimumab | Purity:95% min |
| CAS NO:477202-00-9 | Solubility:Soluble in DMSO |
| Molecular Formula:C6742H9972N1732O2004S40 | Package:Package according to customer requirements |
| Molecular Weight:148634.914 g/mol | Storage:Store at -20℃ |
Quality control
COA
Remarks
Ipilimumab is a monoclonal antibody that works to activate the immune system by targeting CTLA-4, a protein receptor that downregulates the immune system.
Cytotoxic T lymphocytes (CTLs) can recognize and destroy cancer cells. However, an inhibitory mechanism interrupts this destruction. Ipilimumab turns off this inhibitory mechanism and allows CTLs to function.
Related Prodcuts:
Pembrolimumab; Secukinumab; Infliximab; Ramucirumab; Atezolizumab; Daratumumab; Dulaglutide; Rituximab; Adalimumab; Nivolumab; Denosumab; Cetuximab; Bevacizumab; Aflibercept
References
- [1] Hu-Lieskovan S, et al. J Clin Oncol. 2014, 32(21):2248-54.
- [2] Giuseppe Tridente. Adverse Events with Biomedicines, 2013, 251-261.
- [3] Yano H, et al. J Transl Med. 2014, 12:191.
Similar Products
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.
Company
Taizhou Crene Biotechnology Co., Ltd.
Location
Add: Economic Developed Zone of Taizhou Zhejiang China.